Ryan Kerrigan

Edge Rusher

Age: 33
Free Agency: 2022 (Void)
Accrued Seasons: 10
  • 2021 Salary Cap Charge: $1,360,000 (0.66% of cap)
  • 2021 Cash Payout: $2,500,000 (1.19% of spending)
  • 2021 Cash to Cap Ratio: 1.84
  • Contract Value: $2,500,000 ($2,500,000 APY)
  • Fully Guaranteed Money: $2,500,000
  • Contract Ranking: 75/238 at EDGE

Current Contract

(SFA, signed 2021)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202133$1,075,000$285,000$1,075,000$1,360,0000.7%
202234Void$285,000Void$1,140,0000.5%
202335Void$285,000Void$00.0%
202436Void$285,000Void$00.0%
202537Void$285,000Void$0--
Total$1,075,000$1,425,000$1,075,000$2,500,000

Contract Notes

Ryan Kerrigan signed a one year, $2.5 million contract with the Eagles.

Cash Flows

- fully earned money
- unearned or partially earned money
$2.5M
2021
Cash Due$2,500,000
Running Cash$2,500,000
Career Earnings: $74,636,419
Career APY: $7,463,642
Potential Earnings: $75,711,419
Total Guarantees: $35,008,294
Largest Cash Payment: $19,038,000 (2015)
Largest Cap Number: $13,950,000 (2019)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RedskinsDraftedRenegotiated20115$15,758,295$3,151,659$8,720,294$8,720,29455.3%$2,180,074
RedskinsExtensionExpired20155$57,500,000$11,500,000$23,788,000$64,491,125112.2%$10,748,521
EaglesSFAActive20211$2,500,000$2,500,000$2,500,000$1,425,00057.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Washington10$73,211,419$7,321,142$73,195,7940.0%$00.0%
Eagles0$1,425,000$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2011Redskins$375,000$1,210,508$0$375,000$1,585,5081.3%$5,217,032
2012Redskins$771,377$1,210,508$0$771,377$1,981,8851.6%$771,377
2013Redskins$1,167,754$1,210,508$0$1,167,754$2,378,2622.2%$1,167,754
2014Redskins$1,564,131$1,210,508$0$1,564,131$2,774,6392.1%$1,564,131
2015Redskins$2,788,000$3,200,000$250,000$2,788,000$6,238,0004.3%$19,038,000
2016Redskins$5,000,000$3,200,000$250,000$5,000,000$8,450,0005.2%$5,250,000
2017Redskins$8,250,000$3,200,000$250,000$0$11,700,0006.6%$8,500,000
2018Redskins$9,000,000$3,200,000$250,000$0$12,450,0007.0%$9,250,000
2019Redskins$10,500,000$3,200,000$250,000$0$13,950,0007.2%$10,703,125
2020Washington$11,500,000$0$250,000$0$11,687,5005.6%$11,750,000
2021Eagles$1,075,000$285,000$0$1,075,000$1,360,0000.7%$2,500,000
2022Eagles$0$285,000$0$0$1,140,0000.5%$0
2023Eagles$0$285,000$0$0$00.0%$0
2024Eagles$0$285,000$0$0$00.0%$0
2025Eagles$0$285,000$0$0$0--$0
Total$51,991,262$22,267,032$1,500,000$12,741,262$75,695,794$75,711,419

Statistics

YearGames PlayedGames MissedSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
201116----100.0%0.0%42227.555.59144194001
201216----99.2%14.5%42128.551.5101481282101
2013160095.2%18.5%47198.573.51573004000
2014160094.5%16.6%511313.589.518191005100
2015160083.9%13.0%3399.570.512133002000
2016160071.5%15.8%267118415202002000
2017160074.8%18.7%32121162.5141611242001
2018160079.2%15.9%30131396.511191003100
2019124056.9%0.0%1695.534.56141001000
2020160038.0%21.1%985.543561000100

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$0$0
Injury Adjusted$0$0
test
OTC Valuation $3.9M $7.8M $11.7M $15.6M $19.5M APY $3.9M $7.8M $11.8M $15.7M $19.6M $1,167,000 $893,139

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.